調査レポート | • レポートコード：QYR2104Z4786 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、原発性アルドステロン症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、画像検査）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・原発性アルドステロン症の市場動向 ・企業の競争状況、市場シェア ・原発性アルドステロン症の種類別市場規模（血液検査、画像検査） ・原発性アルドステロン症の用途別市場規模（病院、専門クリニック、その他） ・原発性アルドステロン症の北米市場規模2016-2027（アメリカ、カナダ） ・原発性アルドステロン症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・原発性アルドステロン症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・原発性アルドステロン症の中南米市場規模2016-2027（メキシコ、ブラジル） ・原発性アルドステロン症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Sun Pharmaceutical Industries、Bristol Laboratories、CMP Pharma、Koninklijke Philips、GE Healthcare、Siemens、Shimadzu Corporation、Canon） ・結論 |
Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion or headaches.
The treatment for hyperaldosteronism depends on the underlying cause. In people with a single benign tumor (adenoma), surgical removal (adrenalectomy) may be curative. This is usually performed laparoscopically, through several very small incisions. For people with hyperplasia of both glands, successful treatment is often achieved with spironolactone or eplerenone, drugs that block the effect of aldosterone.
Market Analysis and Insights: Global Primary Aldosteronism Market
The global Primary Aldosteronism market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Primary Aldosteronism market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Primary Aldosteronism market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Primary Aldosteronism market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Primary Aldosteronism market.
Global Primary Aldosteronism Scope and Market Size
Primary Aldosteronism market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Primary Aldosteronism market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Blood Test
Imaging Test
Segment by Application
Hospitals
Specialty Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Sun Pharmaceutical Industries
Bristol Laboratories
CMP Pharma
Koninklijke Philips
GE Healthcare
Siemens
Shimadzu Corporation
Canon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Primary Aldosteronism Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Test
1.2.3 Imaging Test
1.3 Market by Application
1.3.1 Global Primary Aldosteronism Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Primary Aldosteronism Market Perspective (2016-2027)
2.2 Primary Aldosteronism Growth Trends by Regions
2.2.1 Primary Aldosteronism Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Primary Aldosteronism Historic Market Share by Regions (2016-2021)
2.2.3 Primary Aldosteronism Forecasted Market Size by Regions (2022-2027)
2.3 Primary Aldosteronism Industry Dynamic
2.3.1 Primary Aldosteronism Market Trends
2.3.2 Primary Aldosteronism Market Drivers
2.3.3 Primary Aldosteronism Market Challenges
2.3.4 Primary Aldosteronism Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Primary Aldosteronism Players by Revenue
3.1.1 Global Top Primary Aldosteronism Players by Revenue (2016-2021)
3.1.2 Global Primary Aldosteronism Revenue Market Share by Players (2016-2021)
3.2 Global Primary Aldosteronism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Primary Aldosteronism Revenue
3.4 Global Primary Aldosteronism Market Concentration Ratio
3.4.1 Global Primary Aldosteronism Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Primary Aldosteronism Revenue in 2020
3.5 Primary Aldosteronism Key Players Head office and Area Served
3.6 Key Players Primary Aldosteronism Product Solution and Service
3.7 Date of Enter into Primary Aldosteronism Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Primary Aldosteronism Breakdown Data by Type
4.1 Global Primary Aldosteronism Historic Market Size by Type (2016-2021)
4.2 Global Primary Aldosteronism Forecasted Market Size by Type (2022-2027)
5 Primary Aldosteronism Breakdown Data by Application
5.1 Global Primary Aldosteronism Historic Market Size by Application (2016-2021)
5.2 Global Primary Aldosteronism Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Primary Aldosteronism Market Size (2016-2027)
6.2 North America Primary Aldosteronism Market Size by Type
6.2.1 North America Primary Aldosteronism Market Size by Type (2016-2021)
6.2.2 North America Primary Aldosteronism Market Size by Type (2022-2027)
6.2.3 North America Primary Aldosteronism Market Size by Type (2016-2027)
6.3 North America Primary Aldosteronism Market Size by Application
6.3.1 North America Primary Aldosteronism Market Size by Application (2016-2021)
6.3.2 North America Primary Aldosteronism Market Size by Application (2022-2027)
6.3.3 North America Primary Aldosteronism Market Size by Application (2016-2027)
6.4 North America Primary Aldosteronism Market Size by Country
6.4.1 North America Primary Aldosteronism Market Size by Country (2016-2021)
6.4.2 North America Primary Aldosteronism Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Primary Aldosteronism Market Size (2016-2027)
7.2 Europe Primary Aldosteronism Market Size by Type
7.2.1 Europe Primary Aldosteronism Market Size by Type (2016-2021)
7.2.2 Europe Primary Aldosteronism Market Size by Type (2022-2027)
7.2.3 Europe Primary Aldosteronism Market Size by Type (2016-2027)
7.3 Europe Primary Aldosteronism Market Size by Application
7.3.1 Europe Primary Aldosteronism Market Size by Application (2016-2021)
7.3.2 Europe Primary Aldosteronism Market Size by Application (2022-2027)
7.3.3 Europe Primary Aldosteronism Market Size by Application (2016-2027)
7.4 Europe Primary Aldosteronism Market Size by Country
7.4.1 Europe Primary Aldosteronism Market Size by Country (2016-2021)
7.4.2 Europe Primary Aldosteronism Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Primary Aldosteronism Market Size (2016-2027)
8.2 Asia-Pacific Primary Aldosteronism Market Size by Type
8.2.1 Asia-Pacific Primary Aldosteronism Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Primary Aldosteronism Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Primary Aldosteronism Market Size by Type (2016-2027)
8.3 Asia-Pacific Primary Aldosteronism Market Size by Application
8.3.1 Asia-Pacific Primary Aldosteronism Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Primary Aldosteronism Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Primary Aldosteronism Market Size by Application (2016-2027)
8.4 Asia-Pacific Primary Aldosteronism Market Size by Region
8.4.1 Asia-Pacific Primary Aldosteronism Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Primary Aldosteronism Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Primary Aldosteronism Market Size (2016-2027)
9.2 Latin America Primary Aldosteronism Market Size by Type
9.2.1 Latin America Primary Aldosteronism Market Size by Type (2016-2021)
9.2.2 Latin America Primary Aldosteronism Market Size by Type (2022-2027)
9.2.3 Latin America Primary Aldosteronism Market Size by Type (2016-2027)
9.3 Latin America Primary Aldosteronism Market Size by Application
9.3.1 Latin America Primary Aldosteronism Market Size by Application (2016-2021)
9.3.2 Latin America Primary Aldosteronism Market Size by Application (2022-2027)
9.3.3 Latin America Primary Aldosteronism Market Size by Application (2016-2027)
9.4 Latin America Primary Aldosteronism Market Size by Country
9.4.1 Latin America Primary Aldosteronism Market Size by Country (2016-2021)
9.4.2 Latin America Primary Aldosteronism Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Primary Aldosteronism Market Size (2016-2027)
10.2 Middle East & Africa Primary Aldosteronism Market Size by Type
10.2.1 Middle East & Africa Primary Aldosteronism Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Primary Aldosteronism Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Primary Aldosteronism Market Size by Type (2016-2027)
10.3 Middle East & Africa Primary Aldosteronism Market Size by Application
10.3.1 Middle East & Africa Primary Aldosteronism Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Primary Aldosteronism Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Primary Aldosteronism Market Size by Application (2016-2027)
10.4 Middle East & Africa Primary Aldosteronism Market Size by Country
10.4.1 Middle East & Africa Primary Aldosteronism Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Primary Aldosteronism Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Primary Aldosteronism Introduction
11.1.4 Pfizer Revenue in Primary Aldosteronism Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Sun Pharmaceutical Industries
11.2.1 Sun Pharmaceutical Industries Company Details
11.2.2 Sun Pharmaceutical Industries Business Overview
11.2.3 Sun Pharmaceutical Industries Primary Aldosteronism Introduction
11.2.4 Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2016-2021)
11.2.5 Sun Pharmaceutical Industries Recent Development
11.3 Bristol Laboratories
11.3.1 Bristol Laboratories Company Details
11.3.2 Bristol Laboratories Business Overview
11.3.3 Bristol Laboratories Primary Aldosteronism Introduction
11.3.4 Bristol Laboratories Revenue in Primary Aldosteronism Business (2016-2021)
11.3.5 Bristol Laboratories Recent Development
11.4 CMP Pharma
11.4.1 CMP Pharma Company Details
11.4.2 CMP Pharma Business Overview
11.4.3 CMP Pharma Primary Aldosteronism Introduction
11.4.4 CMP Pharma Revenue in Primary Aldosteronism Business (2016-2021)
11.4.5 CMP Pharma Recent Development
11.5 Koninklijke Philips
11.5.1 Koninklijke Philips Company Details
11.5.2 Koninklijke Philips Business Overview
11.5.3 Koninklijke Philips Primary Aldosteronism Introduction
11.5.4 Koninklijke Philips Revenue in Primary Aldosteronism Business (2016-2021)
11.5.5 Koninklijke Philips Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Primary Aldosteronism Introduction
11.6.4 GE Healthcare Revenue in Primary Aldosteronism Business (2016-2021)
11.6.5 GE Healthcare Recent Development
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Primary Aldosteronism Introduction
11.7.4 Siemens Revenue in Primary Aldosteronism Business (2016-2021)
11.7.5 Siemens Recent Development
11.8 Shimadzu Corporation
11.8.1 Shimadzu Corporation Company Details
11.8.2 Shimadzu Corporation Business Overview
11.8.3 Shimadzu Corporation Primary Aldosteronism Introduction
11.8.4 Shimadzu Corporation Revenue in Primary Aldosteronism Business (2016-2021)
11.8.5 Shimadzu Corporation Recent Development
11.9 Canon
11.9.1 Canon Company Details
11.9.2 Canon Business Overview
11.9.3 Canon Primary Aldosteronism Introduction
11.9.4 Canon Revenue in Primary Aldosteronism Business (2016-2021)
11.9.5 Canon Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Primary Aldosteronism Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Test
Table 3. Key Players of Imaging Test
Table 4. Global Primary Aldosteronism Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Primary Aldosteronism Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Primary Aldosteronism Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Primary Aldosteronism Market Share by Regions (2016-2021)
Table 8. Global Primary Aldosteronism Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Primary Aldosteronism Market Share by Regions (2022-2027)
Table 10. Primary Aldosteronism Market Trends
Table 11. Primary Aldosteronism Market Drivers
Table 12. Primary Aldosteronism Market Challenges
Table 13. Primary Aldosteronism Market Restraints
Table 14. Global Primary Aldosteronism Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Primary Aldosteronism Market Share by Players (2016-2021)
Table 16. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Aldosteronism as of 2020)
Table 17. Ranking of Global Top Primary Aldosteronism Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Primary Aldosteronism Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Primary Aldosteronism Product Solution and Service
Table 21. Date of Enter into Primary Aldosteronism Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Primary Aldosteronism Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Primary Aldosteronism Revenue Market Share by Type (2016-2021)
Table 25. Global Primary Aldosteronism Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Primary Aldosteronism Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Primary Aldosteronism Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Primary Aldosteronism Revenue Market Share by Application (2016-2021)
Table 29. Global Primary Aldosteronism Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Primary Aldosteronism Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Primary Aldosteronism Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Primary Aldosteronism Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Primary Aldosteronism Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Primary Aldosteronism Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Primary Aldosteronism Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Primary Aldosteronism Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Primary Aldosteronism Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Primary Aldosteronism Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Primary Aldosteronism Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Primary Aldosteronism Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Primary Aldosteronism Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Primary Aldosteronism Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Primary Aldosteronism Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Primary Aldosteronism Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Primary Aldosteronism Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Primary Aldosteronism Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Primary Aldosteronism Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Primary Aldosteronism Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Primary Aldosteronism Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Primary Aldosteronism Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Primary Aldosteronism Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Primary Aldosteronism Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Primary Aldosteronism Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Primary Aldosteronism Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Primary Aldosteronism Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Primary Aldosteronism Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Primary Aldosteronism Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Primary Aldosteronism Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Primary Aldosteronism Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Primary Aldosteronism Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Primary Aldosteronism Product
Table 64. Pfizer Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Sun Pharmaceutical Industries Company Details
Table 67. Sun Pharmaceutical Industries Business Overview
Table 68. Sun Pharmaceutical Industries Primary Aldosteronism Product
Table 69. Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 70. Sun Pharmaceutical Industries Recent Development
Table 71. Bristol Laboratories Company Details
Table 72. Bristol Laboratories Business Overview
Table 73. Bristol Laboratories Primary Aldosteronism Product
Table 74. Bristol Laboratories Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 75. Bristol Laboratories Recent Development
Table 76. CMP Pharma Company Details
Table 77. CMP Pharma Business Overview
Table 78. CMP Pharma Primary Aldosteronism Product
Table 79. CMP Pharma Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 80. CMP Pharma Recent Development
Table 81. Koninklijke Philips Company Details
Table 82. Koninklijke Philips Business Overview
Table 83. Koninklijke Philips Primary Aldosteronism Product
Table 84. Koninklijke Philips Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 85. Koninklijke Philips Recent Development
Table 86. GE Healthcare Company Details
Table 87. GE Healthcare Business Overview
Table 88. GE Healthcare Primary Aldosteronism Product
Table 89. GE Healthcare Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 90. GE Healthcare Recent Development
Table 91. Siemens Company Details
Table 92. Siemens Business Overview
Table 93. Siemens Primary Aldosteronism Product
Table 94. Siemens Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 95. Siemens Recent Development
Table 96. Shimadzu Corporation Company Details
Table 97. Shimadzu Corporation Business Overview
Table 98. Shimadzu Corporation Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 99. Shimadzu Corporation Recent Development
Table 100. Canon Company Details
Table 101. Canon Business Overview
Table 102. Canon Primary Aldosteronism Product
Table 103. Canon Revenue in Primary Aldosteronism Business (2016-2021) & (US$ Million)
Table 104. Canon Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Primary Aldosteronism Market Share by Type: 2020 VS 2027
Figure 2. Blood Test Features
Figure 3. Imaging Test Features
Figure 4. Global Primary Aldosteronism Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Primary Aldosteronism Report Years Considered
Figure 9. Global Primary Aldosteronism Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Primary Aldosteronism Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Primary Aldosteronism Market Share by Regions: 2020 VS 2027
Figure 12. Global Primary Aldosteronism Market Share by Regions (2022-2027)
Figure 13. Global Primary Aldosteronism Market Share by Players in 2020
Figure 14. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Aldosteronism as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Primary Aldosteronism Revenue in 2020
Figure 16. Global Primary Aldosteronism Revenue Market Share by Type (2016-2021)
Figure 17. Global Primary Aldosteronism Revenue Market Share by Type (2022-2027)
Figure 18. North America Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Primary Aldosteronism Market Share by Type (2016-2027)
Figure 20. North America Primary Aldosteronism Market Share by Application (2016-2027)
Figure 21. North America Primary Aldosteronism Market Share by Country (2016-2027)
Figure 22. United States Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Primary Aldosteronism Market Share by Type (2016-2027)
Figure 26. Europe Primary Aldosteronism Market Share by Application (2016-2027)
Figure 27. Europe Primary Aldosteronism Market Share by Country (2016-2027)
Figure 28. Germany Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Primary Aldosteronism Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Primary Aldosteronism Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Primary Aldosteronism Market Share by Region (2016-2027)
Figure 38. China Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Primary Aldosteronism Market Share by Type (2016-2027)
Figure 46. Latin America Primary Aldosteronism Market Share by Application (2016-2027)
Figure 47. Latin America Primary Aldosteronism Market Share by Country (2016-2027)
Figure 48. Mexico Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Primary Aldosteronism Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Primary Aldosteronism Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Primary Aldosteronism Market Share by Country (2016-2027)
Figure 54. Turkey Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Primary Aldosteronism Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 58. Sun Pharmaceutical Industries Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 59. Bristol Laboratories Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 60. CMP Pharma Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 61. Koninklijke Philips Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 62. GE Healthcare Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 63. Siemens Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 64. Shimadzu Corporation Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 65. Canon Revenue Growth Rate in Primary Aldosteronism Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の原発性線毛機能不全市場規模・現状・予測（2021年-2027年） Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube…- 世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
- 世界の原発性免疫不全症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Immunodeficiency Diseases Treatment Market The global Primary Immunodeficiency Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …
- 世界の一次フレキシブル電池市場 2021：企業別、地域別、種類・用途別 The Primary Flexible Battery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の一次金属乾燥機市場 2021：企業別、地域別、種類・用途別 The Primary Metal Drier market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…